Literature DB >> 11545479

Chlamydia pneumoniae DNA in the arterial wall of patients with peripheral vascular disease.

J Gutiérrez1, J Linares-Palomino, C Lopez-Espada, M Rodríguez, E Ros, G Piédrola, M C del Maroto.   

Abstract

BACKGROUND: Chlamydia pneumoniae is a human respiratory pathogen that has recently been related to the genesis of symptomatic atherosclerosis. C. pneumoniae has been studied more widely in relation to coronary atherosclerosis than to peripheral arterial occlusive disease (PAOD). The present study aimed to retrospectively analyze the presence of C. pneumoniae DNA in patients with PAOD.
MATERIALS AND METHODS: A seminested PCR method was applied on 85 samples from 71 patients with PAOD secondary to surgical treatment. The control group comprised 50 patients with chronic superficial venous insufficiency who required varicose resection surgery.
RESULTS: The number of patients, number of samples studied and percentage of patients found to be positive in the PCR study were 17, 18 and 59%, respectively, for arteries of the lower extremities; 15, 16 and 60% for aneurysm of the abdominal aorta; 22, 23 and 73% for carotid stenosis and 17, 18 and 65% for aortic stenosis. C. pneumoniae DNA was found in six external pudendal arteries (12%) of the control group, significantly lower than the incidence in the patient group (p < 0.0001).
CONCLUSION: A causal relationship between chronic C. pneumoniae infection and PAOD cannot be ruled out. On the contrary, the high incidence of C. pneumoniae DNA detected in our patients suggests that C. pneumoniae infection may play some role in the pathogenesis of peripheral vascular disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11545479     DOI: 10.1007/s15010-001-1180-0

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  4 in total

1.  Determinants of lumbar artery occlusion among patients with sciatica: a three-year follow-up with magnetic resonance angiography.

Authors:  Jaro Karppinen; Mauno Kurunlahti; Simo Taimela; Marianne Haapea; Heikki Vanharanta; Osmo Tervonen
Journal:  Eur Spine J       Date:  2005-02-19       Impact factor: 3.134

2.  Chlamydia pneumoniae and Cardiovascular Disease.

Authors:  Maria Kolia; Ignatius William Fong
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

3.  Chlamydia pneumoniae aggravates vein graft intimal hyperplasia in a rat model.

Authors:  Geoffrey T L Kloppenburg; Rick de Graaf; Gert E L M Grauls; Cathrien A Bruggeman; Frank R Stassen
Journal:  BMC Microbiol       Date:  2007-12-06       Impact factor: 3.605

4.  Evaluation of five DNA extraction methods for purification of DNA from atherosclerotic tissue and estimation of prevalence of Chlamydia pneumoniae in tissue from a Danish population undergoing vascular repair.

Authors:  Tina Mygind; Lars Østergaard; Svend Birkelund; Jes S Lindholt; Gunna Christiansen
Journal:  BMC Microbiol       Date:  2003-09-02       Impact factor: 3.605

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.